1701 records, the earliest from 22 Oct 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
1701 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Category | Subject |
|---|---|---|
| 1 Oct 2026 | Company Update | Biocon Ltd - 532523 - Grant Of Employee Stock Options Under Biocon Unity Long Term Incentive Plan 2026 Read With The Notified Plans Thereunder |
| 1 Oct 2026 16:02 | Options to purchase securities | Biocon Limited has informed the Exchange about Grant of Employee Stock Options under Biocon Unity Long Term Incentive Plan 2026 read with the Notified Plans thereunder |
| 30 Sep 2026 | Insider Trading / SAST | Biocon Ltd - 532523 - Closure of Trading Window |
| 30 Sep 2026 14:12 | Trading Window | Biocon Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 25 Sep 2026 | Company Update | Biocon Ltd - 532523 - Company Secretary |
| 25 Sep 2026 03:05 | Updates | Biocon Limited has informed the Exchange regarding 'Company Statement'. |
| 21 Sep 2026 | Company Update | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| 21 Sep 2026 02:56 | Press Release | Biocon Limited has informed the Exchange regarding a press release dated September 21, 2026, titled "Biocon s Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach". |
| 9 Sep 2026 | Company Update | Biocon Ltd - 532523 - Communication Regarding Remittance Of Final Dividend For The FY 2025-26 |
| 9 Sep 2026 08:28 | General Updates | Biocon Limited has informed the Exchange about Communication regarding remittance of final dividend for the FY 2025-26 |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
